As the only commercial company that participated in this groundbreaking study, we are proud to see how our NAi platform and multiomics expertise are driving scientific innovation and advancing ...
PRNewswire/ - Esphera SynBio, a pre-clinical stage synthetic biology company, today announced a new project aimed at advancing next-generation mRNA vaccines. Using its proprietary technology, ...